Bronstein, Gewirtz & Grossman LLC announces that Exscientia plc investors who have suffered substantial losses have the opportunity to pursue a class action lawsuit!

NEW YORK, May 8, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Exscientia plc (“Exscientia” or ” the Company”) (NASDAQ: EXAI) and certain of its officers.

Class definition:

This lawsuit seeks damages against the defendants for alleged violations of the federal securities laws on behalf of all persons and entities who purchased or otherwise acquired Exscientia securities between March 23, 2022 And February 12, 2024, inclusive (the “Class Period”). These investors are encouraged to join this deal by visiting the company’s website: bgandg.com/EXAI.

Case details:

According to the complaint, Exscientia is an artificial intelligence (“AI”)-driven pharmaceutical technology company engaged in the design and development of differentiated medicines for diseases with significant unmet patient needs.

At all relevant times, according to the complaint, the company has purported to “maintain() the highest standards of business conduct and ethics” and, to that end, has adopted a code of business conduct and ethics that applies to all its employees and managers. , and directors, including the former president and chief executive officer (“CEO”) and the defendant director Andrew Hopkins (“Hopkins”), former Chairman of the Board of Directors of the Company (the “Board”) Defendant David Nicholson (“Nicholson”), as well as all other directors and senior managers.

The complaint alleged that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose the following:

(1) Defendant Hopkins engaged in inappropriate relationships with employees that were not consistent with the Company’s standards and values;

(2) Defendant Nicholson had prior knowledge of Defendant Hopkins’ dealings and inappropriately addressed Hopkins’ misconduct without consulting the Commission;

(3) the Company’s maintenance and enforcement of its Code of Business Conduct and Ethics was inadequate to guard against the foregoing conduct;

(4) the foregoing failures have subjected the Company to increased risk of disruptive leadership transitions and/or reputational damage; And

(5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

On February 13, 2024, Exscientia issued a press release “announcing that its Board of Directors (the “Board”) has decided to terminate the employment of (Defendant) Hopkins as (CEO) and Managing Director of the Company, and to dismiss Dr. Hopkins. from his role as executive director of the council, in each case for good cause and with immediate effect. The press release further reveals that the Commission’s decision was made following an investigation which revealed that respondent Hopkins had “established relationships with two employees that the Commission found to be inappropriate and inconsistent with the standards and the values ​​of the company. Additionally, the press release stated that during the course of the investigation, the Commission learned that “(defendant) Nicholson … had prior knowledge of the existence of the first of Dr. Hopkins’ relationships and had directly addressed the situation. , and with the participation of other external counsel, rather than in consultation with the Board of Directors”, and “(following discussions with the Board of Directors, on February 12, 2024 Dr. Nicholson has tendered his resignation from his position with the company.

On this news, the Exscientia share price fell $1.72 per share, or 22.9%, to close at $5.79 per share on February 13, 2024according to the complaint.

As a result, according to the complaint, as a result of Defendants’ wrongful acts and omissions and the precipitous decline in the market value of the Company’s securities, investors suffered significant losses and damages.

And after?

A class action lawsuit has already been filed. If you would like to view a copy of the complaint, you can visit the firm’s website: bgandg.com/EXAI or you can contact Peretz Bronstein, Esq. or its Customer Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you have suffered a loss in Exscientia, you have until June 25, 2024, to ask the court to appoint you as lead plaintiff. Your ability to participate in any recovery does not require that you be the lead plaintiff.

There is no cost to you

We represent investors in class actions on a contingency fee basis. This means that we will ask the court to reimburse us for out-of-pocket expenses and attorney’s fees, usually a percentage of the total recovery, only if we win our case.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm representing securities investors. fraud class actions and derivative suits between shareholders. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Lawyer advertising. Previous results do not guarantee similar results.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein Or Nathan Miller,

332-239-2660 | (email protected)

SOURCE Bronstein, Gewirtz & Grossman, LLC